The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Open accessAbstract
Expression of HPV16 early region genes in basal keratinocytes of transgenic mice elicits a multistage pathway to squamous carcinoma. We report that infiltration by mast cells and activation of the matrix metalloproteinase MMP-9/gelatinase B coincides with the angiogenic switch in premalignant lesions. Mast cells infiltrate hyperplasias, dysplasias, and invasive fronts of carcinomas, but not the core of solid tumors, where they degranulate in close apposition to capillaries and epithelial basement membranes, releasing mast-cell-specific serine proteases MCP-4 (chymase) and MCP-6 (tryptase). MCP-6 is shown to be a mitogen for dermal fibroblasts that proliferate in the reactive stroma, whereas MCP-4 can activate progelatinase B and induce hyperplastic skin to become angiogenic in an in vitro bioassay. Notably, premalignant angiogenesis is abated in a mast-cell-deficient (KITW/KITWWv) HPV16 transgenic mouse. The data indicate that neoplastic progression in this model involves exploitation of an inflammatory response to tissue abnormality. Thus, regulation of angiogenesis during squamous carcinogenesis is biphasic: In hyperplasias, dysplasias, and invading cancer fronts, inflammatory mast cells are conscripted to reorganize stromal architecture and hyperactivate angiogenesis; within the cancer core, upregulation of angiogenesis factors in tumor cells apparently renders them self-sufficient at sustaining neovascularization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genetic and functional experiments indicate that neutrophils, mast cells, eosinophils and activated T lymphocytes also contribute to malignancies by releasing extracellular proteases, pro-angiogenic factors and chemokines11,23–26.”
From Inflammation and cancer (2002) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Self-citationWhat Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,509
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
RAG-1-deficient mice have no mature B and T lymphocytes
Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S., & Papaioannou, V. E. (1992) · Cell · doi:10.1016/0092-8674(92)90030-g · Cited by 2,898
Proteins: Structures and Molecular Properties
Creighton, T. E. (1986) · Medical Entomology and Zoology · Cited by 2,645
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,737
Self-citationThe proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus
Chabot, B., Stephenson, D. A., Chapman, V. M., Besmer, P., & Bernstein, A. (1988) · Nature · doi:10.1038/335088a0 · Cited by 1,339
Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation
Kitamura, Y., Go, S.-R., & Hatanaka, K. (1978) · Blood · doi:10.1182/blood.v52.2.447.bloodjournal522447 · Cited by 830
Research works printed but not linked: 3
- Caughey, G.H. 1995. Mast cell chymases and tryptases: Phylog- eny, family relations, and biogenesis. In Mast cell proteases in immunology and biology (ed. G.H. Caughey), pp. 305- 329.
- Folkman, J. and D. Hanahan. 1991. Expression of the angiogenic phenotype during development of murine and human can- cer. In Origins of human cancer: A comprehensive review (ed. J. Brugge, J. Curran, E. Harlow, and F. McCormick), pp. 803-814. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
- Westphal, E. 1891. Uber mastzellen. In Farbenanalytische Ut- ersuchuugen zur Histologie und Klinik des Blutes: gesam- melte Mitt(h)eilungen (ed. P. Ehrlich), Vol. 1, p. 17. Hirsch- wald Press, Berlin, Germany.
Cited by
Sorted by citations
Items 901–945 of 945
Benzo(a)Pyrene-Induced Oxidative Stress During Lung Cancer and Treatment with Baicalein
Chandrashekar, N. (2022) · Springer eBooks · doi:10.1007/978-981-15-9411-3_183
(2002) · Cancer Immunology Immunotherapy · doi:10.1007/s262-002-0291-5
IMPORTANCIA DEL MICROAMBIENTE TUMORAL EN LA PROGRESIÓN DEL CÁNCER DE MAMA
Valdivia‐Silva, J. (2019) · Revista ECIPeru · doi:10.33017/reveciperu2008.0005/
Angiogenesis and mast cells as predictive factors in behavior of Odontogenic cysts
(2020) · Mansoura Journal of Dentistry · doi:10.21608/mjd.2020.200152
“However, stimulatory role of mast cells in the growth of pathological lesions is more prevalent and obvious than their inhibitory effect ((28)).”
BackgroundMarshall, J. S., Portales‐Cervantes, L., & Dawod, B. (2019) · Encyclopedia of Gastroenterology · doi:10.1016/b978-0-12-801238-3.65915-9
Tumor microenvironment manipulation and cancer metastasis (taming the beast)
Khamis, Y., & Arafat, W. O. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821789-4.00003-5 · Cited by 1
Disección mecanística del fracaso loco-regional en cáncer de mama
de Córdoba, B. R. (2022) · Deposito Adademico Digital Universidad De Navarra (University of Navarra) · doi:10.15581/10171/63818
Immune-Endocrine Perspectives of Breast Cancer
Saini, K. S., Suman, S., & Konwar, R. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781681089522112010005
Letter to the Editor: Mast cells in tumors. First evidence
Ribatti, D. (2023) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.63.4.09
“In the 20 years, mouse experimental models, such as MC-deficient W/Wv mice and human papillomavirus type 16 (HPV16) transgenic mouse model of squamous epithelial carcinoma [5, 6], and clinical studies in human patients have improved our knowledge on the role of MCs in tumor progression.”
Molecular Mechanisms Driving Bone Metastasis of Cancers
Qiu, F., Huang, J., Fu, X., & Liang, C. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_80-1
Evaluation of Mast Cell Density in Mucoepidermoid Carcinoma and Pleomorphic Adenoma.
Jalili, A., Jafari, N., & Tabatabaei, S. H. (2023) · PubMed Central · doi:10.30476/dentjods.2022.93712.1730
“MCs-secreted mediators such as vascular endothelial growth factor and interleukin 8 can play a role in the formation of blood vessels and suppression of the immune system and provide the conditions for tumor formation [12].”
BackgroundMethodInfluentialMultistage Carcinogenesis: Cell and Animal Models
Kulesz-Martin, M. F., Ouyang, X., Ramin, S., Barling, A. N., Gallegos, J. R., Liu, Y., & Medler, T. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00085-1
Koudstaal, T., Bogaard, H. J., & Boomars, K. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-822951-4.00019-9
Inflammatory markers related to survival in breast cancer patients: Peru
Cruz-Vargas, J. A. D. L., Roldán-Arbieto, L., Palomino, R. M., Ferrer-Ponce, D. I., Anccas, C. F., Correa-López, L. E., Beltrán, B., & Vela-Ruiz, J. M. (2024) · The International Journal of Biological Markers · doi:10.1177/03936155241283480
Mast Cells in and Their Cellular Interactions Within the Tumor Environment
Jackson, C. W., Reji, M. A., Pratt, C. M., Nguyen, S. M. T., & Krishnaswamy, G. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_21-1
Mast Cells in Allergy, Host Defense and Immune Regulation
Marshall, J. S., Nanjundappa, R. H., Barra, J., Portales‐Cervantes, L., & Haidl, I. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00190-3
Kumar, S., Chan, C. J., Coussens, L. M., Whiteside, S. K., & Roychoudhuri, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00164-2
Self-citationMast Cells in and Their Cellular Interactions Within the Tumor Environment
Jackson, C. W., Reji, M. A., Pratt, C. M., Nguyen, S. M. T., & Krishnaswamy, G. A. (2025) · Springer eBooks · doi:10.1007/978-3-032-00749-0_21
Gao, X., Cao, S., Ren, H., Wang, X., Chen, J., & Huang, H. (2025) · Discover Medicine · doi:10.1007/s44337-025-00361-2
Targeting innate and adaptive immunity to suppress lung cancer metastasis
Qin, R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1662754
Immunity and tolerance to the tumor-associated antigen MUC1
Ryan, S. O. (2009) · D-Scholarship@Pitt (University of Pittsburgh)
Intravital imaging in the study of tumor microenvironment and its role in tumor growth.
Olow, A. (2012) · Utrecht University Repository (Utrecht University)
Fang, S. (2014) · Työväentutkimus Vuosikirja
Glioma as an Ecosystem : Studies of Invasion, Onco-miR Addiction and Mast Cell Infiltration
Põlajeva, J. (2012) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Jia, X.-H., Geng, L.-Y., Jiang, P.-P., Xu, H., Nan, K.-J., Yao, Y., Jiang, L.-L., Sun, H., Qin, T.-J., & Guo, H. (2020) · Figshare · doi:10.6084/m9.figshare.13468451
Jia, X.-H., Geng, L.-Y., Jiang, P.-P., Xu, H., Nan, K.-J., Yao, Y., Jiang, L.-L., Sun, H., Qin, T.-J., & Guo, H. (2020) · Figshare · doi:10.6084/m9.figshare.13468447
Molecular Mechanisms Driving Bone Metastasis of Cancers
Qiu, F., Huang, J., Fu, X., & Liang, C. (2025) · Springer eBooks · doi:10.1007/978-3-032-00759-9_80
Deciphering the Role of Mast Cells in HPV-Related Cancers
Espinosa-Riquer, Z. P., Muñoz-Bello, J. O., González‐Espinosa, C., Ibarra-Sánchez, A., & Lizano, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412110
“In this murine model, HPV16-harboring epithelia recruit higher numbers of MCs compared to wild type (WT) animals [120–123].”
Chronic Urticaria and Malignancy: A Review Uncovering the Common Links
Lekli, E., Hoxha, M., Bova, M., Gjonbrataj, J., Mati, K., Vyshka, G., & Qirko, E. (2026) · Biomedicines · doi:10.3390/biomedicines14010229
Caractérisation de BMP9 (Bone Morphogenetic Protein 9), un nouveau biomarqueur de l'angiogenèse ?
Bidart, M. (2012) · theses.fr (ABES) · doi:10.70675/224671deza4d5z423dzb13azb79bb3a18370
Rôle des mastocytes dans le développement des astrocytomes humains : implication du récepteur CD47
Boukhari, A. A. (2012) · theses.fr (ABES) · doi:10.70675/3c922fc3z5510z47b6zba8ezeb4143cfb7ba
Contribution à l'étude du rôle de CD146 soluble dans les pathologies angiogéniques
Stalin, J. (2014) · theses.fr (ABES) · doi:10.70675/987330a7zf9b1z4179z90fbzf2c1119eb37b
Jacqueline, C. M. (2017) · theses.fr (ABES) · doi:10.70675/d539649bz1298z4794zab28z3d5d7540c85f
Strategies of Cancer Immunotherapy : Model of Triple Negative Breast Cancer
Kishi, M. (2019) · theses.fr (ABES) · doi:10.70675/51302a51z120az4319z9cebzc7a90f0976ce
CRISPR approaches: Modeling tumor-stroma interactions and their role in cancer progression
Raninga, B., & Gupta, P. S. (2026) · Gene Reports · doi:10.1016/j.genrep.2026.102569
Identification of functional genes and immune cell infiltration analysis in liposarcoma
Liu, C., Wang, Y., Liu, Q., & Zhang, S. (2026) · PLoS ONE · doi:10.1371/journal.pone.0358180
“The exact role (pro-or anti-tumorigenic) of MCs in LPS is likely context-dependent and warrants further investigation [37,38].”
Bodduluri, S. R. (2013) · doi:10.18297/etd/120
“Mast cells were found to stimulate tumor growth by producing proteases and angiogenesis factors in mouse models of skin [47] and pancreatic cancers [48].”
BackgroundInitiation and regulation of effector T cell responses in the prostate
Haverkamp, J. M. (2011) · doi:10.17077/etd.qb7bm0ex
“MC infiltration into pre-malignant tissue is critical for malignant transformation during skin cancer and for tumor growth in established tumors (117-118).”
Hematopoietic Stem Cells and Angiogenesis
Takakura, N. (2003) · Developments in cardiovascular medicine · doi:10.1007/978-1-4419-9264-2_35
STRATEGIES TO TARGET CHEMOTHERAPEUTICS TO TUMORS
Albright, C. F., & Huang, P. S. (2006) · Elsevier eBooks · doi:10.1016/b978-012088561-9/50004-1
Metadata
- Authors
- Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D.
- Affiliations
- University of California, San Francisco (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1999-06-01
- Volume
- 13
- Issue
- 11
- Pages
- 1382-1397
- ISSN
- 0890-9369 (ISSN-L)
- PMC
- PMC316772
- OpenAlex
- W2146440075
- Cited by
- 946
- References
- 87
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 11 · 2023: 13 · 2022: 27 · 2021: 18 · 2020: 29 · 2019: 31 · 2018: 27 · 2017: 29 · 2016: 39 · 2015: 32 · 2014: 52 · 2013: 32 · 2012: 49
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL 24136, P01HL024136)
- National Cancer Institute (CA72006, P01CA072006)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- mast cells, angiogenesis, squamous cell carcinoma, HPV16, keratinocytes, MMP-9, chymase, tryptase, precancerous lesions, dermal fibroblasts, tumor stroma, inflammation, carcinogenesis, neovascularization
- MeSH terms
- Animals, Carcinoma, Squamous Cell, Extracellular Matrix, Humans, Mast Cells, Mice, Transgenic, Neovascularization, Pathologic, Serine Endopeptidases, Up-Regulation, Inflammation Mediators, Mice, Tryptases, Chymases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
